March 02, 2005
Tamoxifen and Endometrial Cancer Risk
A new study confirms tamoxifen can boost the risk of endometrial cancer in pre-menopausal and postmenopausal women. The risk increases the longer a woman takes the drug.
A new study confirms tamoxifen can boost the risk of endometrial cancer in pre-menopausal and postmenopausal women. The risk increases the longer a woman takes the drug.